TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

Market News Page 62 of 160 • 3,996 articles
Inventiva annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris
GlobeNewswire Inc. • Inventiva
Inventiva annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris

11/13/2025 02:40 AM • Inventiva, a biopharmaceutical company, will temporarily suspend trading on Euronext Paris for a public offering of American Depositary Shares in the United States, with trading expected to resume around 15:30 CET.

BACpK - Largest retail bank in the US, 'too big to fail' status, diversified banking operations, and consistent dividend yield
IVA - The company is conducting a standard public offering with a planned temporary stock suspension, which is a routine financial procedure without clear positive or negative implications
#stock suspension #public offering #ADSs #Nasdaq #Euronext Paris
Read More
CIIE Turns Exhibitors into “Die-hard Fans”
GlobeNewswire Inc. • People'S Daily Overseas Edition
CIIE Turns Exhibitors into “Die-hard Fans”

11/13/2025 02:37 AM • The 8th China International Import Expo showcased international business success stories, with companies from Peru, New Zealand, Japan, and Colombia highlighting significant growth and market expansion through collaborative trade opportunities.

BACpM - Largest retail bank in the US, 'too big to fail' status, diversified banking operations, and consistent dividend yield
SONY - Exploring cultural content exchange and product displays, emphasizing diversification beyond electronics
#international trade #import expo #global business #market expansion #cross-border collaboration
Read More
Equinor ASA: Ex. Dividend second quarter 2025 today – OSE
GlobeNewswire Inc. • Na
Equinor ASA: Ex. Dividend second quarter 2025 today – OSE

11/13/2025 01:53 AM • Equinor ASA announced its second quarter 2025 cash dividend of $0.37 per share, with ex-dividend date set for November 13, 2025. The company also executed debt capital market transactions and continued its share buy-back program.

KMB - Strategic expansion of portfolio by acquiring Kenvue, gaining 10 billion-dollar brands and projected $2.1 billion in synergies
EQNR - The article describes routine financial activities like dividend distribution and market transactions without indicating significant positive or negative business developments
#dividend #share buy-back #debt capital market #stock exchange
Read More
Equinor ASA: Eks utbytte andre kvartal 2025 i dag – OSE
GlobeNewswire Inc. • Na
Equinor ASA: Eks utbytte andre kvartal 2025 i dag – OSE

11/13/2025 01:53 AM • Equinor ASA announced its second quarter 2025 dividend of $0.37 per share, with ex-dividend date set for November 13, 2025. The company also executed debt capital market transactions and continued its share buy-back program.

EQNR - Routine financial activities including dividend distribution and capital market transactions suggest stable corporate operations without significant positive or negative indicators
#dividend #share buy-back #capital markets #stock transaction
Read More
Walt Disney Q4 2025 Earnings Preview: Wall Street Sees a 2026 Comeback
Investing.com • Ali Merchant
Walt Disney Q4 2025 Earnings Preview: Wall Street Sees a 2026 Comeback

11/13/2025 01:45 AM • Disney is preparing to report Q4 2025 earnings, with investors focused on its streaming transformation, potential ESPN expansion, and theme park performance amid challenging market conditions.

DIS - Mixed outlook with projected revenue growth of 1%, streaming expansion plans, but potential challenges from linear TV decline and theme park competition
#streaming #Disney+ #earnings #ESPN #theme parks
Read More
Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire Inc. • Annexon, Inc.
Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants

11/12/2025 10:55 PM • Annexon, a biopharmaceutical company, announced a public offering of 25,096,153 shares of common stock and pre-funded warrants, expecting to raise $75 million to support its neuroinflammation research platform.

ANNX - The company is raising capital through a public offering, which indicates a standard financial strategy for funding research and development without strong positive or negative implications
#public offering #neuroinflammation #biopharmaceutical #stock #warrants
Read More
James Hardie Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against James Hardie Industries plc - JHX
GlobeNewswire Inc. • Claimsfiler
James Hardie Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against James Hardie Industries plc - JHX

11/12/2025 10:39 PM • James Hardie Industries faces a class action lawsuit alleging failure to disclose material information about declining North America Fiber Cement sales, resulting in a 34% stock price drop.

JHX - Company disclosed unexpected 12% sales decline in North America Fiber Cement segment, leading to significant stock price drop and potential legal action from shareholders
#securities class action #shareholder lawsuit #stock disclosure #fiber cement
Read More
Six Flags Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Six Flags Entertainment Corporation - FUN
GlobeNewswire Inc. • Claimsfiler
Six Flags Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Six Flags Entertainment Corporation - FUN

11/12/2025 10:35 PM • Six Flags faces a class action lawsuit alleging material information was not disclosed during its merger with Cedar Fair, resulting in significant stock price decline from over $55 to $20 per share.

FUN - Lawsuit alleges executives failed to disclose critical financial information, implemented aggressive cost-cutting measures that degraded operational competence, and caused a 64% stock price decline following merger
#merger #securities lawsuit #stock decline #Cedar Fair #investment
Read More
Marex Group Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Marex Group plc - MRX
GlobeNewswire Inc. • Claimsfiler
Marex Group Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Marex Group plc - MRX

11/12/2025 10:33 PM • NINGI Research alleges Marex Group engaged in accounting misconduct, including fictitious transactions, misleading disclosures, and concealing off-balance-sheet derivatives exposure, leading to a 6.2% stock price drop.

MRX - Accused of multiple accounting irregularities including creating fictitious receivables, inflating profits, concealing losses, and misrepresenting financial information, which resulted in stock price decline and potential legal action
#securities lawsuit #accounting fraud #off-balance-sheet entities #derivatives exposure
Read More
Securities Fraud Investigation Into Perrigo Company plc (PRGO) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Benzinga • Business Wire
Securities Fraud Investigation Into Perrigo Company plc (PRGO) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

11/12/2025 09:36 PM • Law Offices of Frank R. Cruz announces investigation into Perrigo Company for potential securities law violations after stock price dropped 25.2% following lowered financial guidance and strategic review of infant formula business.

PRGO - Company lowered full year guidance, disclosed strategic review of infant formula business, experienced significant stock price decline of 25.2%, and is now subject to a potential securities fraud investigation
#securities fraud #financial results #stock price drop #investor loss
Read More
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Synopsys, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SNPS
GlobeNewswire Inc. • Rosen Law Firm
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Synopsys, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SNPS

11/12/2025 08:48 PM • Rosen Law Firm is notifying Synopsys investors of a securities class action lawsuit alleging the company made false or misleading statements about its business operations, particularly regarding artificial intelligence customer impacts.

SNPS - Lawsuit alleges company made materially false statements about business operations, specifically concerning AI customer economics and potential negative financial impacts, suggesting potential misconduct or misrepresentation
#securities class action #investor rights #artificial intelligence #financial disclosure
Read More
Caring Brands Announces Pricing of $4,000,000 Million Uplisting to Nasdaq
GlobeNewswire Inc. • Brian S John
Caring Brands Announces Pricing of $4,000,000 Million Uplisting to Nasdaq

11/12/2025 07:58 PM • Caring Brands, Inc. announced a public offering of 1,000,000 common shares at $4.00 per share, raising approximately $4 million. The company plans to list on Nasdaq Capital Markets under the ticker 'CABR' and use proceeds for working capital, marketing, and debt repayment.

CBRA - The company is expanding its market presence through a public offering, seeking capital for growth, and transitioning to a more prestigious stock exchange, indicating strategic business development
#public offering #Nasdaq #wellness products #stock listing
Read More
Entrepreneur Universe Bright Group Reports Third Quarter 2025 Financial Results
Benzinga • Prnewswire
Entrepreneur Universe Bright Group Reports Third Quarter 2025 Financial Results

11/12/2025 07:47 PM • Entrepreneur Universe Bright Group reported a decline in financial performance for Q3 2025, with revenues dropping 27% and net income decreasing 44% compared to the same quarter in 2024, while maintaining a strong cash position of $9.56 million.

CRWV - Has a $30.1 billion revenue backlog, posted triple-digit revenue growth, received strategic investment from Nvidia, and offers specialized GPU cloud services for AI training and inference
EUBG - Experienced significant revenue and net income declines (27% and 44% respectively) in Q3 2025, indicating challenging market conditions and potential business performance issues
#digital marketing #financial results #China #consulting services #e-commerce
Read More
Farmers & Merchants Bancorp (FMCB) Announces Record Quarterly Dividend
GlobeNewswire Inc. • Kent A. Steinwert
Farmers & Merchants Bancorp (FMCB) Announces Record Quarterly Dividend

11/12/2025 06:45 PM • Farmers & Merchants Bancorp declared a quarterly cash dividend of $5.05 per share, reporting strong financial performance with net income of $23.7 million in Q3 2025, a 13.2% increase from the previous year.

BYDDY - World's largest EV manufacturer, experimenting with long-range solid-state batteries
FMCB - Strong financial results with 13.2% earnings increase, 90 consecutive years of dividend payments, ranked 17th among Dividend Kings, and recognized as a top-performing bank
#dividend #banking #financial performance #earnings #agriculture
Read More
Why Clearwater Analytics Was Quite a Winner on Wednesday
The Motley Fool • Eric Volkman
Why Clearwater Analytics Was Quite a Winner on Wednesday

11/12/2025 06:31 PM • Clearwater Analytics saw its stock rise nearly 8% after Bloomberg reported the company is exploring potential sale options and attracting interest from potential buyers.

MBGYY - Testing solid-state battery technology with plans to integrate by 2030
CWAN - Stock price increased by 7.55% on speculation of potential takeover, with Bloomberg reporting the company has drafted advisors to explore sale options and solicit buyer interest
#acquisition #financial software #potential sale #stock market
Read More
INSP: Kirby McInerney LLP Advises Inspire Medical Systems, Inc. Investors of Class Action Lawsuit
GlobeNewswire Inc. • Kirby Mcinerney Llp
INSP: Kirby McInerney LLP Advises Inspire Medical Systems, Inc. Investors of Class Action Lawsuit

11/12/2025 06:00 PM • A securities class action lawsuit has been filed against Inspire Medical Systems alleging false statements about product launch and demand, resulting in significant stock price decline.

INSP - Stock price dropped 32.35% after revealing launch challenges, reduced 2025 earnings guidance by over 80%, and admitting poor product demand and implementation issues with Inspire V medical device
#securities fraud #medical device #sleep apnea #stock decline
Read More
From Pennsylvania Roots to Beatport Charts: Jason Kushy’s Relentless Drive Powers a Global Music Journey
GlobeNewswire Inc. • Jason Kushy
From Pennsylvania Roots to Beatport Charts: Jason Kushy’s Relentless Drive Powers a Global Music Journey

11/12/2025 05:54 PM • Jason Kushy, a Monterey-based house DJ and Navy Officer, achieved a Top 20 Beatport chart position with his debut EP 'Keep It Moving', demonstrating a disciplined approach to independent music production and brand building.

SPOT - Mentioned as a streaming platform for Kushy's music, with no specific positive or negative context
#house music #DJ #electronic music #independent artist #Beatport #Navy #entrepreneurship
Read More
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages James Hardie Industries plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – JHX
GlobeNewswire Inc. • Rosen Law Firm
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages James Hardie Industries plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – JHX

11/12/2025 05:53 PM • Rosen Law Firm alerts James Hardie Industries investors about a potential securities class action lawsuit alleging the company misled investors about its North America Fiber Cement segment's performance between May 20 and August 18, 2025.

SM - The merger is expected to be immediately accretive to key metrics, create significant free cash flow exceeding $1.4 billion, and maintain sustainable dividends
JHX - The lawsuit alleges the company falsely claimed demand remained strong and stock levels were 'normal' despite knowing distributors were destocking inventory, suggesting potential intentional misrepresentation of financial performance
#securities #class action #investor rights #misleading statements
Read More
Anteris Announces Results for the Third Quarter of 2025
GlobeNewswire Inc. • Wayne Paterson
Anteris Announces Results for the Third Quarter of 2025

11/12/2025 05:52 PM • Anteris Technologies received FDA approval to commence patient recruitment for its PARADIGM Trial, evaluating the DurAVR® Transcatheter Heart Valve across the United States, Europe, and Canada. The company advanced regulatory activities, strengthened operational systems, and reported $59.3 million in net operating cash outflows for the first nine months of 2025.

AVR - Achieved key regulatory milestones for PARADIGM Trial, secured first patient enrollments in Denmark, advanced manufacturing capabilities, and maintained strategic focus on clinical development
#DurAVR® THV #PARADIGM Trial #FDA approval #transcatheter heart valve #clinical trial
Read More
SAGA Metals Announces Brokered LIFE Offering for Gross Proceeds of up to C$5 Million
GlobeNewswire Inc. • Mike Stier
SAGA Metals Announces Brokered LIFE Offering for Gross Proceeds of up to C$5 Million

11/12/2025 05:51 PM • SAGA Metals Corp. is conducting a private placement offering to raise between C$3-5 million to fund exploration of critical mineral properties in Labrador, Canada, including the Radar Titanium Project and Double Mer Uranium Project.

VWAGY - Committed to EV transition, partnering with QuantumScape, aiming for significant EV sales by 2030
RIO - Mentioned as a partnership partner for SAGA's Legacy Lithium Property project
#private placement #critical minerals #exploration #titanium #uranium #Labrador
Read More
Fiserv, Inc. (FI) Faces Lawmakers’ Scrutiny After Admission to Objectively Difficult-to-Achieve Guidance Assumptions, “‘Abysmal’” Q3 2025 Results – Hagens Berman
GlobeNewswire Inc. • Hagens Berman
Fiserv, Inc. (FI) Faces Lawmakers’ Scrutiny After Admission to Objectively Difficult-to-Achieve Guidance Assumptions, “‘Abysmal’” Q3 2025 Results – Hagens Berman

11/12/2025 05:45 PM • Fiserv admitted to unrealistic financial guidance assumptions, leading to a 47% stock price drop and attracting Senate Democrats' investigation into former CEO Frank Bisignano's role in financial forecasting.

TM - Exploring solid-state battery technology, planning first solid-state EV launch in 2027
FI - Company missed financial targets, experienced significant stock price decline, faced potential securities fraud lawsuit, and is under Senate investigation for potentially misleading investors about growth prospects
#securities fraud #financial guidance #stock price drop #investor losses
Read More
Navient declares fourth quarter common stock dividend
GlobeNewswire Inc. • Navient
Navient declares fourth quarter common stock dividend

11/12/2025 05:00 PM • Navient declared a quarterly dividend of $0.16 per share, payable on December 19, 2025, to shareholders of record as of December 5, 2025.

PFE - Included in key players list with broad pharmaceutical portfolio, but no specific PID treatment innovations mentioned
JSM - The announcement is a standard financial disclosure of a dividend payment, indicating stable corporate operations without significant positive or negative implications
#dividend #quarterly earnings #shareholder #financial announcement
Read More
North American Construction Group Ltd. Announces Results for the Third Quarter Ended September 30, 2025
GlobeNewswire Inc. • Joe Lambert, President And Ceo
North American Construction Group Ltd. Announces Results for the Third Quarter Ended September 30, 2025

11/12/2025 05:00 PM • North American Construction Group reported Q3 2025 revenue of $390.8 million, a 6% increase from the previous year, driven by growth in the Australian segment. Despite increased revenue, gross profit decreased 23%, and adjusted EPS dropped 44% to $0.67.

JNJ - Listed as a key player with diversified healthcare, but no direct connection to PID treatment highlighted
NOA - Mixed financial performance with revenue growth but decreased profitability, indicating challenges in maintaining margins despite increased business volume
#construction #mining services #financial results #revenue #earnings
Read More
OTC Markets Group Reports Third Quarter 2025 Financial Results Delivering Strong Revenue, Operating Income, and Earnings Growth
GlobeNewswire Inc. • Otc Markets Group Inc.
OTC Markets Group Reports Third Quarter 2025 Financial Results Delivering Strong Revenue, Operating Income, and Earnings Growth

11/12/2025 05:00 PM • OTC Markets Group reported strong financial performance in Q3 2025, with gross revenues of $31.6 million (up 15%), operating income of $10.6 million (up 23%), and net income of $8.6 million. The company highlighted growth across OTC Link, Market Data Licensing, and Corporate Services segments.

OTCM - Strong financial performance with double-digit growth in revenues, operating income, and net income. Successful launch of OTCID Basic Market and continued expansion of corporate services.
#financial results #revenue growth #market data #corporate services #trading platforms
Read More
Novartis Phase III trial for next-generation malaria treatment KLU156 (GanLum) meets primary endpoint, with potential to combat antimalarial resistance
GlobeNewswire Inc. • Novartis Media Relations
Novartis Phase III trial for next-generation malaria treatment KLU156 (GanLum) meets primary endpoint, with potential to combat antimalarial resistance

11/12/2025 05:00 PM • Novartis announced successful Phase III trial results for KLU156 (GanLum), a novel malaria treatment with potential to combat drug-resistant parasites, achieving a 97.4% PCR-corrected cure rate across 12 African countries.

NVS - Successfully completed Phase III trial for innovative malaria treatment, demonstrating high efficacy and potential to address drug resistance
#malaria #drug resistance #antimalarial #clinical trial #ganaplacide
Read More